Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Canada / NCT03720197
Recruiting Observational

Registry of Patients Living With Type 1 Diabetes

NCT03720197 · tracked via the Priya Life Science Canada tracker
Sponsor
Institut de Recherches Cliniques de Montreal
Phase
Observational
Started
2019-02-20
Last updated
2025-02-25

Condition(s) studied

Type 1 Diabetes Mellitus

Investigational drug(s) / intervention(s)

Online questionnaire - Phase 1Online questionnaire - Phase 2Online questionnaire - Phase 3Food questionnairePedometerWaist circumferenceBlood and urine testsList of medicationsContinuous glucose monitor

Online questionnaire - Phase 1: Draw an overall picture of the population with type 1 diabetes in Canada in terms of demographics, diabetes treatment, hypoglycemia frequency and diabetes complications.

Online questionnaire - Phase 2: Characterize the causes, experience and consequences of hypoglycemia.

Online questionnaire - Phase 3: Collect information on diabetes and hypoglycemia treatment, hyperglycemia management, sleep habits, depression, physical activity and the benefits of technologies to reduce the frequency of hypoglycemia.

Food questionnaire: 24-hour food recall questionnaire

Pedometer: Participants will wear a podometer for 14 consecutives days

Waist circumference: Participants will be asked to measure their waist circumference

Blood and urine tests: Participants will be invited to send us their latests blood and urine test results.

List of medications: Participants will be invited to send us their list of medications

Continuous glucose monitor: Participants will be invited to send us the latest report of their continuous glucose monitor

Study summary

A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc.

Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of type 1 diabetes * Living in Canada Exclusion Criteria: * Type 2 diabetes * Gestational diabetes

Primary outcome measure(s)

Trial sites (7)

FacilityCityRegionStatus
Alberta Diabetes Institute Edmonton Alberta Recruiting
Institut de recherches cliniques de Montréal Montreal Quebec Recruiting
Centre Hospitalier de l'Université de Montréal Montreal Quebec Recruiting
Centre Hospitalier Universitaire Sainte-Justine Montreal Quebec Recruiting
McGill University Health Centre Montreal Quebec Recruiting
Centre Hospitalier Universitaire de Québec-Université Laval Québec Quebec Recruiting
Centre hospitalier universitaire de Sherbrooke Sherbrooke Quebec Recruiting

More Institut de Recherches Cliniques de Montreal trials in Canada

Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis Recruiting
NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems Starting soon
Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes Recruiting
Functional Mobility and Resistance Exercise for Postmenopausal Females With Type 1 Diabetes Starting soon
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes Recruiting

Other trials for the same condition

VV-14300 for the Treatment of Type 1 Diabetes Starting soon
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus Recruiting
How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver Starting soon
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar Recruiting
Simultaneous Measurement and Responsive Treatment - Part 2 Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03720197 on ClinicalTrials.gov ↗ ← All trials in Canada